Nuclear Diamond Batteries Subsidiary AtomiQ Signs Strategic MOU with Curio to Advance Domestic Radioisotope Supply for Nuclear Batteries

NDBI’s AtomiQ signed a non-binding MOU with Curio to explore domestic radioisotope supply.

What the company is saying

Nuclear Diamond Batteries, Inc., through its majority-owned subsidiary AtomiQ, is highlighting a Memorandum of Understanding with Curio to explore technical collaboration and potential future supply of strontium-90 and americium-241 for nuclear battery applications. The announcement frames this as a strategic step toward securing domestic sources of critical radioisotopes, which have historically been limited in the U.S. The company emphasizes the potential for Curio’s NuCycle process to recover valuable isotopes from used nuclear fuel, supporting AtomiQ’s development of long-duration nuclear-voltaic power sources. Executives Dr. Greg Rubin (AtomiQ CEO) and Edward McGinnis (Curio CEO) both stress the importance of reliable domestic supply chains and the broader commercial and national security opportunities. The tone is optimistic but careful to clarify that the MOU is preliminary, non-exclusive, and does not commit either party to purchases, supply volumes, or delivery schedules. The announcement also details AtomiQ’s intellectual property portfolio, including U.S. Patents 12,394,534 and 12,759,882, and a third U.S. application with a Notice of Allowance.

What the data suggests

The MOU is non-binding and does not establish any committed purchases, supply volumes, delivery schedules, or contract value. AtomiQ’s IP portfolio includes two issued U.S. patents—12,394,534 (nuclear-voltaic power-source architecture) and 12,759,882 (carbon nano-onion nanomaterial synthesis)—and a third application with a Notice of Allowance. Curio’s NuCycle technology is described as designed to reduce nuclear waste requiring permanent disposal by up to 97%, but this is stated as a design goal, not a realised outcome. Curio has achieved lab-scale validation, is working with six U.S. Department of Energy national laboratories, has secured millions in competitive federal grants, and is partnered with Utilities Service Alliance to explore opportunities involving 18 operating U.S. reactors. No financial figures, revenue, or operational metrics for NDBI or AtomiQ are disclosed. All commercial outcomes, technical work, and supply arrangements remain contingent on future agreements, technical validation, regulatory authorizations, and facility readiness. The collaboration is non-exclusive, and both parties remain free to pursue other opportunities.

Analysis

The announcement is positive in tone, highlighting a new MOU between AtomiQ and Curio to explore technical collaboration and potential future supply of radioisotopes. However, the actual measurable progress is limited: the MOU is non-binding, does not commit to purchases, supply volumes, or delivery schedules, and any commercial outcome is contingent on future agreements, technical validation, and regulatory approvals. Most key claims are forward-looking, focusing on what the companies intend to explore or assess rather than realised achievements. While Curio's NuCycle technology is described as 'designed to reduce nuclear waste by up to 97%' and has achieved lab-scale validation, there is no evidence of commercial-scale deployment or immediate impact. The announcement references millions in federal grants and partnerships, but these are not quantified or linked to near-term revenue or profit. The gap between narrative and evidence is moderate: the language suggests strategic significance and future opportunity, but the only realised fact is the signing of a preliminary MOU.

Risk flags

• ●There is no binding commitment to supply, purchase, or deliver radioisotopes, so the MOU may not result in any commercial transaction. This limits the immediate value to investors and leaves all outcomes contingent on future negotiations and technical milestones.
• ●Execution risk is high, as the collaboration depends on successful technical validation, regulatory approvals, and facility readiness before any commercial supply can begin. These steps can take years and may encounter unforeseen technical or regulatory barriers.
• ●Curio’s NuCycle technology is described as achieving lab-scale validation and being designed to reduce nuclear waste by up to 97%, but there is no evidence of commercial-scale deployment or independent validation of these claims. The gap between lab-scale success and commercial reality is significant in the nuclear sector.
• ●The announcement provides no financial data, revenue projections, or cost estimates for NDBI or AtomiQ, making it impossible to assess the financial impact or runway for either company. The lack of disclosed financials increases uncertainty for investors.
• ●The collaboration is non-exclusive, so either party may pursue similar partnerships with other companies, potentially diluting any future competitive advantage or supply security that might result from this relationship.

Bottom line

This announcement signals that NDBI’s AtomiQ is seeking to secure a future domestic supply of critical radioisotopes by partnering with Curio, but the agreement is non-binding and purely exploratory at this stage. No commercial, technical, or financial milestones have been achieved; all outcomes depend on future technical validation, regulatory approvals, and new agreements. The most concrete facts are AtomiQ’s two issued U.S. patents (12,394,534 and 12,759,882) and Curio’s lab-scale validation and partnerships, but there is no evidence of near-term revenue or operational impact. Investors should treat this as an early-stage signal of intent rather than a catalyst for value realization. The most important takeaway is that while the market opportunity for long-duration nuclear batteries is real, this MOU does not materially de-risk NDBI’s pathway to commercialisation or supply security. Future updates should be scrutinized for binding agreements, technical milestones, and quantified financial impacts.

Announcement summary

(OTCID:NDBI) Nuclear Diamond Batteries, Inc. announced that its majority-owned subsidiary, AtomiQ, Inc., has signed a Memorandum of Understanding (MOU) with Curio Legacy Ventures, Inc., doing business as Curio, a nuclear technology company developing the NuCycle® used nuclear fuel recycling process. The MOU establishes a framework for the companies to explore technical collaboration and potential future supply of strontium-90 (Sr-90) and americium-241 (Am-241), two radioisotopes with potential applications in long-duration power technologies. Curio's NuCycle® process is being developed to recover valuable materials, including radioisotopes, from used nuclear fuel, with the aim of creating new domestic supply chains for strategic nuclear materials. The companies intend to evaluate how Curio's isotope recovery capabilities could support AtomiQ's development of diamond and carbon-based nuclear-voltaic power sources. The collaboration will initially focus on assessing technical feasibility, isotope characteristics, potential supply requirements, and regulatory considerations for future commercial applications. Key areas of potential collaboration include exploring a domestic supply pathway for Sr-90 and Am-241, assessing isotope specifications and suitability for AtomiQ's technologies, evaluating licensing and material handling requirements, and identifying potential government, research, and commercial applications for domestically sourced radioisotopes and long-duration nuclear power systems. The MOU is a preliminary framework and does not establish committed purchases, supply volumes, delivery schedules, or contract value. Any future supply, technical work, material transfers, or commercial arrangements would require separate agreements, technical validation, regulatory authorizations, and facility readiness. Dr. Greg Rubin, Chief Executive Officer of AtomiQ, Inc., stated that reliable access to appropriately characterized radioisotopes is important for advancing nuclear battery technology and that domestic sources of Sr-90 and Am-241 have historically been limited. Edward McGinnis, President and Chief Executive Officer of Curio, stated that Curio's NuCycle technology is designed to transform used nuclear fuel into valuable resources, including critical radioisotopes, and that the collaboration with AtomiQ highlights commercial opportunities for recovered isotopes and the importance of a reliable domestic supply chain. AtomiQ's intellectual property portfolio includes two issued U.S. patents: U.S. Patent No. 12,394,534 (nuclear-voltaic power-source architecture) and U.S. Patent No. 12,759,882 (carbon nano-onion nanomaterial synthesis), and a third U.S. application with a Notice of Allowance covering its metal-organic-framework electrode structure. Curio's NuCycle technology is designed to reduce the volume of nuclear waste requiring permanent disposal by up to 97%. Curio has achieved lab-scale validation, is working across six U.S. Department of Energy national laboratories, has secured millions in competitive federal grants, and has partnered with Utilities Service Alliance (USA) to explore collaboration and supplier-partner opportunities involving its 18 operating U.S. member reactors. Curio’s NuCycle® technology was recognized as a winner of Fast Company’s 2026 World Changing Ideas Awards. The collaboration is non-exclusive, and both companies remain free to pursue other research, commercial, and strategic opportunities. Any future supply or development arrangements will be established through separate agreements.

Disagree with this article?